181 related articles for article (PubMed ID: 25356951)
1. Evaluation of in-line Raman spectroscopic monitoring of size reduction during wet media milling of Biopharmaceutics Classification System Class II drugs.
Ying Y; Afolabi A; Bilgili E; Iqbal Z
Appl Spectrosc; 2014; 68(12):1411-7. PubMed ID: 25356951
[TBL] [Abstract][Full Text] [Related]
2. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
3. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
5. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
6. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
Li M; Alvarez P; Bilgili E
Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
[TBL] [Abstract][Full Text] [Related]
7. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
Afolabi A; Akinlabi O; Bilgili E
Eur J Pharm Sci; 2014 Jan; 51():75-86. PubMed ID: 24036164
[TBL] [Abstract][Full Text] [Related]
8. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.
Kumar S; Burgess DJ
Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581
[TBL] [Abstract][Full Text] [Related]
9. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Bhakay A; Azad M; Vizzotti E; Dave RN; Bilgili E
Drug Dev Ind Pharm; 2014 Nov; 40(11):1509-22. PubMed ID: 23981202
[TBL] [Abstract][Full Text] [Related]
10. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
[TBL] [Abstract][Full Text] [Related]
11. Melt milling as manufacturing method for solid crystalline suspensions.
da Igreja P; Erve A; Thommes M
Eur J Pharm Biopharm; 2021 Jan; 158():245-253. PubMed ID: 33253891
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of multiple solvent induced form changes during high shear wet granulation and drying processes using online Raman spectroscopy.
Reddy JP; Jones JW; Wray PS; Dennis AB; Brown J; Timmins P
Int J Pharm; 2018 Apr; 541(1-2):253-260. PubMed ID: 29481947
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
Krull SM; Ma Z; Li M; Davé RN; Bilgili E
Drug Dev Ind Pharm; 2016; 42(7):1073-85. PubMed ID: 26567632
[TBL] [Abstract][Full Text] [Related]
14. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Bhakay A; Azad M; Bilgili E; Dave R
Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
[TBL] [Abstract][Full Text] [Related]
15. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
Bilgili E; Li M; Afolabi A
Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
[TBL] [Abstract][Full Text] [Related]
16. Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.
Li M; Alvarez P; Orbe P; Bilgili E
AAPS PharmSciTech; 2018 May; 19(4):1789-1801. PubMed ID: 29603084
[TBL] [Abstract][Full Text] [Related]
17. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
Feng T; Bates S; Carvajal MT
Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
[TBL] [Abstract][Full Text] [Related]
18. Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs.
Parker N; Rahman M; Bilgili E
Eur J Pharm Biopharm; 2020 Aug; 153():52-67. PubMed ID: 32522681
[TBL] [Abstract][Full Text] [Related]
19. Scale-up from batch to flow-through wet milling process for injectable depot formulation.
Lehocký R; Pěček D; Štěpánek F
Eur J Pharm Sci; 2016 Dec; 95():122-129. PubMed ID: 27568853
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of a pharmaceutical nanomilling process using grating light reflection spectroscopy.
Hamad ML; Kailasam S; Brodsky AM; Han R; Higgins JP; Thomas D; Reed RA; Burgess LW
Appl Spectrosc; 2005 Jan; 59(1):16-25. PubMed ID: 15720733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
